NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Management of Patients With COVID-19

Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial - The

13 Things To Know About Paxlovid, the Latest COVID-19 Pill > News

Critical study of Gilead drug shows coronavirus patients

Cureus Compassionate Use of Remdesivir in Pregnancy: A Case

Efficacy Data for COVID-19

COVID-19 Treatment Algorithms

Study will evaluate remdesivir for COVID-19 in pregnant women

Comparative therapeutic efficacy of remdesivir and combination

Guidelines for COVID-19 Management in Hematopoietic Cell